STEMCELL Journal Club: Patient-Derived Alzheimer’s Disease Modeling
In this Journal Club, Dr. Erin Knock discusses the applications of pluripotent stem cell-derived lines to investigate Alzheimer’s Disease. The featured paper is Ortiz-Virumbrales et al.’s CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer’s PSEN2N141I neurons.
Publish Date: May 25, 2020
Views: 0
Related Multimedia
-
29:15STEMCELL Journal Club: Mechanisms of Glioblastoma Resistance
Publish Date: May 25, 2020 -
28:45STEMCELL Journal Club: Cerebral Organoids for Human-Specific Infection Modeling
Publish Date: May 25, 2020 -
53:16Modeling Genetic Epilepsies with Induced Pluripotent Stem Cells
Publish Date: June 01, 2017
Explore Our Products
-
NeuroCult™ SM1 Neuronal Supplement
Supplement for the serum-free culture of primary tissue-derived neurons and hPSC-derived neural progenitor cells -
Serum-free neurophysiological basal medium for improved neuronal function -
STEMdiff™ SMADi Neural Induction Kit
Serum-free medium kit for highly efficient SMAD inhibition-mediated neural induction of human ES and iPS cells -
cGMP, stabilized feeder-free maintenance medium for human ES and iPS cells